Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cecilia Melo-Alvim"'
Autor:
Joaquim Soares do Brito, Miguel Esperança-Martins, André Abrunhosa-Branquinho, Cecilia Melo-Alvim, Raquel Lopes-Brás, João Janeiro, Dolores Lopez-Presa, Isabel Fernandes, José Portela, Luis Costa
Publikováno v:
Cancers. 14:2546
Bone sarcomas (BS) are rare mesenchymal tumors usually located in the extremities and pelvis. While surgical resection is the cornerstone of curative treatment, some locally advanced tumors are deemed unresectable and hence not suitable for curative
Autor:
Patrícia Miguel-Semedo, Ana Rita Sousa, Emanuel Gouveia, Helena Luna Pais, Luis Costa, Soraia Lobo Martins, Maria-Jose Saramago Passos, Cecilia Melo Alvim Moreira, André Mansinho, Diogo Martins-Branco, Ines Vendrell, Ana Maria Monteiro
Publikováno v:
Journal of Clinical Oncology. 37:135-135
135 Background: Immunotherapy (IO) has changed the disease course of metastatic malignant melanoma (mMM). Prognostic biomarkers are lacking, but high neutrophil-lymphocyte ratio (NLR) has been correlated with poor outcome. Lymphocyte-monocyte ratio (
Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives.
Autor:
Soares do Brito, Joaquim1 (AUTHOR) 20781@chln.min-saude.pt, Esperança-Martins, Miguel2,3 (AUTHOR) 20781@chln.min-saude.pt, Abrunhosa-Branquinho, André4 (AUTHOR) andre.branquinho@chln.min-saude.pt, Melo-Alvim, Cecilia2 (AUTHOR) raquel.bras@chln.min-saude.pt, Lopes-Brás, Raquel2 (AUTHOR) 15673@chln.min-saude.pt, Janeiro, João5 (AUTHOR) joao_janeiro@sapo.pt, Lopez-Presa, Dolores6 (AUTHOR) doloreslopez@chln.min-saude.pt, Fernandes, Isabel2,3 (AUTHOR) luis.costa@chln.min-saude.pt, Portela, José1 (AUTHOR), Costa, Luis2,3 (AUTHOR)
Publikováno v:
Cancers. May2022, Vol. 14 Issue 10, p2546-N.PAG. 24p.
Publikováno v:
Clinical Oncology Week; 8/22/2023, p955-955, 1p
Publikováno v:
Cancer Weekly; 9/26/2023, p645-645, 1p
Autor:
Daniela Macedo, Luis Costa, Isabel Fernandes, André Mansinho, R. Paiva, Leonor Ribeiro, C. Alvim, Carolina Borges da Ponte, José Palma dos Reis, R. Brás, Soraia Lobo-Martins, P. Semedo
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Future Science OA
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Future Science OA
© Cecilia Melo Alvim. This work is licensed under the Creative Commons Attribution4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Aim: To evaluate prostate-specific antigen response (PSAr) defined
Aim: To evaluate prostate-specific antigen response (PSAr) defined
Autor:
Rakesh Kumar, Paul B. Fisher
Receptor Tyrosine Kinases, Volume 147 in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research in the area of Receptor Tyrosine Kinases (RTKs) in the context of major basic sc